▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #280 by analyst upside · 2026-06-27
BHST
BioHarvest Sciences Inc. Common Stock
Consumer Defensive · Market Cap $63M · P/E 0x
ANALYST PRICE TARGET
+360.3%
implied upside to consensus target
Current Price $2.77
Consensus Target $12.75
Bull Target $15.0
Bear Target $10.0
Analysts Covering 4
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
3
Hold
0
Sell
0
52-Week Low $2.75
52-Week High $12.8
YTD Return -46.8%
FUNDAMENTALS
Market Cap $63M
P/E Ratio (TTM) N/A
Forward P/E -16.8x
EPS (TTM) $-0.57
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $35M
Profit Margin -32.5%
52-WEEK RANGE
52-Week Low $2.75
52-Week High $12.8
Current Price $2.77
Bear Target $10.0
Bull Target $15.0
● Now $2.77 ● Target $12.75
TRADING DATA
Avg Volume 31K
YTD Return -46.8%
Analyst Count 4
Consensus Buy
Upside to Target +360.3%
Last Updated 2026-06-27

ANALYST SUMMARY

BioHarvest Sciences Inc. Common Stock (BHST) is currently trading at $2.77 with a Wall Street consensus price target of $12.75, implying potential upside of 360.3% over the next 12 months. 4 analysts currently cover BHST, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $15.0, while the most cautious has a target of $10.0.

BHST operates in the Consumer Defensive sector with a market capitalisation of $63M. The stock is down 46.8% year-to-date and is currently trading near the lower end of its 52-week range of $2.75 – $12.8.

SIMILAR STOCKS

Other Consumer Defensive stocks with comparable size and valuation.

VFF +160.1%
Village Farms International, In
$230M · P/E 8.2x · Buy
USNA +88.4%
USANA Health Sciences, Inc.
$382M · P/E 41.4x · Hold
MH +91.4%
McGraw Hill, Inc.
$2B · P/E 49.9x · Buy
DDL +75.3%
Dingdong (Cayman) Limited
$418M · P/E 17.4x · Buy
CELH +96.1%
Celsius Holdings, Inc.
$8B · P/E 69.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for BHST, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Roth Capital ● Initiated
Buy 2026-02-19 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-04-08 31% win rate (48 calls)
Maxim Group ● Initiated
Buy 2024-12-18 28% win rate (40 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-12-11 31% win rate (48 calls)
HC Wainwright & Co. ● Initiated
Buy 2024-12-06 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →